Is there any relationship between expressions of minor blood group antigens with HTLV-I infection?
The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infecti...
Saved in:
Published in | Transfusion and apheresis science Vol. 47; no. 2; pp. 151 - 154 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.10.2012
|
Subjects | |
Online Access | Get full text |
ISSN | 1473-0502 1878-1683 |
DOI | 10.1016/j.transci.2012.06.012 |
Cover
Abstract | The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran.
In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009–2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software.
The prevalence of Lea, Leb, P1, Fya, Fyb, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens.
Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran. |
---|---|
AbstractList | The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran.BACKGROUNDThe frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran.In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software.METHODSIn this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software.The prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens.RESULTSThe prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens.Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.CONCLUSIONOur study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran. The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. The prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran. The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009–2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. The prevalence of Lea, Leb, P1, Fya, Fyb, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran. Background: The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. Methods: In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24 h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. Results: The prevalence of Lea, Leb, P1, Fya, Fyb, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. Conclusions: Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran. AbstractBackgroundThe frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran. MethodsIn this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009–2010. Blood group antigens were determined by tube method less than 24 h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software. ResultsThe prevalence of Le a, Le b, P1, Fy a, Fy b, M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens. ConclusionOur study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran. |
Author | Sadeghian, Mohammad Hadi Tehranaian, Farahnaz Keramati, Mohammad Reza Shakibyee, Hossein Ayatollahi, Hossein Feizabadi, Atefeh Shirinzadeh |
Author_xml | – sequence: 1 givenname: Mohammad Hadi surname: Sadeghian fullname: Sadeghian, Mohammad Hadi organization: Cancer Molecular Pathology Research Center, Ghaem Hospital, Department of Hematology and Blood Bank, Faculty of Medicine, Mashhad University of Medical Sciences (MUMS), Iran – sequence: 2 givenname: Mohammad Reza surname: Keramati fullname: Keramati, Mohammad Reza email: keramatimr@Mums.ac.ir organization: Neonatal Research Center, Imam Reza Hospital, Faculty of Medicine, MUMS, Iran – sequence: 3 givenname: Hossein surname: Ayatollahi fullname: Ayatollahi, Hossein organization: Department of Hematology and Blood Bank, Faculty of Medicine, MUMS, Iran – sequence: 4 givenname: Atefeh Shirinzadeh surname: Feizabadi fullname: Feizabadi, Atefeh Shirinzadeh organization: Cancer Molecular Pathology Research Center, Ghaem Hospital, Faculty of Medicine, MUMS, Iran – sequence: 5 givenname: Farahnaz surname: Tehranaian fullname: Tehranaian, Farahnaz organization: Blood Transfusion Center of Khorasan Razavi, Iran – sequence: 6 givenname: Hossein surname: Shakibyee fullname: Shakibyee, Hossein organization: Blood Transfusion Center of Khorasan Razavi, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22858444$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUs1u3CAYRFWq5qd5hFYce7EDGIytqo2iqElWWqmHprkijD9n2XrBBbvpvn1xdnOJVCWnD8HMADNzjA6cd4DQB0pySmh5ts7HoF00NmeEspyUeRpv0BGtZJXRsioO0prLIiOCsEN0HOOaECppXb5Dh4xVouKcH6FmEfG4ggBYuy0O0OvRehdXdsANjA8ADsPfIUCM8zb2Hd5Y5wNueu9bfB_8NCTmaO8hnT7YcYVvbpd32QJb14GZtc7fo7ed7iOc7ucJ-nn17fbyJlt-v15cXiwzI4gcM2aoEFA0mmtKad1RojkxhHdVLQkX0LbQAZQm_d6UtAYjqkqCIS00hEvJihP0aac7BP97gjiqjY0G-l478FNUlNQFl7ym5SughWScM14l6Mc9dGo20Koh2I0OW_VkYQJ83gFM8DEG6JSx46OLKSDbJy01B6bWah-YmgNTpFRpJLZ4xn664CXe-Y4HydE_FoJKCHAGWhuS76r19kWFr88UTG-dNbr_BVuIaz8Fl-JSVMXEUT_mMs1doiz1SJQiCXz5v8ArHvAPR_PcTA |
CitedBy_id | crossref_primary_10_1002_jcp_28087 crossref_primary_10_1080_00032719_2017_1287714 crossref_primary_10_1007_s12288_015_0620_4 |
Cites_doi | 10.1128/JVI.01522-06 10.1157/13079179 10.1016/j.chom.2008.06.002 10.3109/10428191003611436 10.1016/j.chom.2009.04.010 10.1007/s11899-007-0035-x 10.1182/blood-2004-11-4267 10.1182/blood-2009-04-215186 10.1111/j.1349-7006.2011.01907.x 10.1089/aid.2006.0140 10.4103/0973-6247.53884 10.1128/IAI.72.6.3429-3435.2004 10.1038/sj.onc.1208968 10.1186/1742-4690-2-27 10.1128/JVI.00389-06 10.1016/j.carres.2007.12.012 10.1182/blood-2010-01-261859 10.3748/wjg.14.4265 10.1080/00313020903041010 10.11150/kansenshogakuzasshi1970.79.664 10.1017/S0950268809991117 10.1186/1742-4690-4-31 10.1089/aid.2008.0002 10.1097/MOH.0b013e32833ece31 10.1016/S0753-3322(99)80021-3 |
ContentType | Journal Article |
Copyright | 2012 Elsevier Ltd Elsevier Ltd Copyright © 2012 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2012 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2012 Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7U9 H94 |
DOI | 10.1016/j.transci.2012.06.012 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Virology and AIDS Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1878-1683 |
EndPage | 154 |
ExternalDocumentID | 22858444 10_1016_j_transci_2012_06_012 S1473050212001565 1_s2_0_S1473050212001565 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UHS UNMZH Z5R ~G- AACTN AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD 7U9 H94 |
ID | FETCH-LOGICAL-c507t-2c155e3ba4a1119f10a40c04f897045eddefee6c101c619ec5887ec0deb047723 |
IEDL.DBID | .~1 |
ISSN | 1473-0502 |
IngestDate | Sun Sep 28 08:29:42 EDT 2025 Sat Sep 27 19:52:17 EDT 2025 Mon Jul 21 05:55:53 EDT 2025 Tue Jul 01 02:22:47 EDT 2025 Thu Apr 24 23:09:30 EDT 2025 Fri Feb 23 02:27:57 EST 2024 Sun Feb 23 10:18:44 EST 2025 Tue Aug 26 18:00:25 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Virus HTLV-I Blood group |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2012 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c507t-2c155e3ba4a1119f10a40c04f897045eddefee6c101c619ec5887ec0deb047723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 22858444 |
PQID | 1037244248 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1093474916 proquest_miscellaneous_1037244248 pubmed_primary_22858444 crossref_citationtrail_10_1016_j_transci_2012_06_012 crossref_primary_10_1016_j_transci_2012_06_012 elsevier_sciencedirect_doi_10_1016_j_transci_2012_06_012 elsevier_clinicalkeyesjournals_1_s2_0_S1473050212001565 elsevier_clinicalkey_doi_10_1016_j_transci_2012_06_012 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-10-01 |
PublicationDateYYYYMMDD | 2012-10-01 |
PublicationDate_xml | – month: 10 year: 2012 text: 2012-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Transfusion and apheresis science |
PublicationTitleAlternate | Transfus Apher Sci |
PublicationYear | 2012 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Jones, Fugo, Petrow-Sadowski, Huang, Bertolette, Lisinski (b0110) 2006; 80 Lachgar, Jaureguiberry, Le Buenac, Bizzini, Zagury, Rappaport (b0130) 1998; 52 Yamaoka (b0065) 2008; 14 Proietti, Carneiro-Proietti, Catalan-Soares, Murphy (b0010) 2005; 24 Ukaejiofo, Nubila (b0140) 2006; 25 Sadeghian, Keramati, Badiei (b0090) 2009; 3 Anstee (b0045) 2010; 115 Moran (b0070) 2008; 343 Behal, Jain, Behal, Dhole (b0055) 2010; 138 Miyoshi, Yoshizumi, Sato, Okui, Ogawa, Honma (b0080) 2005; 79 Neil, McKnight, Gustafsson, Weiss (b0120) 2005; 105 He, Neil, Kulkarni, Wright, Agan, Marconi (b0085) 2008; 4 Beadling (b0035) 2007 González-Ordóñez (b0075) 2005; 125 Caskey, Morgan, Porto, Giozza, Muniz, Orge (b0030) 2007 Mar; 23 Winkler, An, Johnson, Nelson, Kirk (b0125) 2009; 5 Kulkarni, Marconi, He, Landrum, Okulicz, Delmar (b0135) 2009; 114 Nakao, Matsuo, Hosono, Ogata, Ito, Watanabe (b0050) 2011; 102 Kinet, Swainson, Lavanya, Mongellaz, Montel-Hagen, Craveiro (b0105) 2007; 15 Branch (b0095) 2010; 17 Takenouchi, Jones, Lisinski, Fugo, Yao, Cushman (b0115) 2007; 81 Tarhini, Kchour, Zanjani, Rafatpanah, Otrock, Bazarbachi (b0025) 2009; 41 Matsuoka (b0100) 2005; 26 Ayatollahi, Rafatpanah, Khayyami, Sayyadpour, Ravarian, Sadeghian (b0020) 2008; 24 Mahieux, Gessain (b0005) 2007; 2 Hennig, Mernaugh, Edl, Cao, Cover (b0060) 2004; 72 Keramati, Sadeghian, Ayatollahi (b0015) 2010 Apr; 51 Calhoun, Petz (b0040) 2010 Proietti (10.1016/j.transci.2012.06.012_b0010) 2005; 24 Branch (10.1016/j.transci.2012.06.012_b0095) 2010; 17 Jones (10.1016/j.transci.2012.06.012_b0110) 2006; 80 Behal (10.1016/j.transci.2012.06.012_b0055) 2010; 138 Mahieux (10.1016/j.transci.2012.06.012_b0005) 2007; 2 Ukaejiofo (10.1016/j.transci.2012.06.012_b0140) 2006; 25 Caskey (10.1016/j.transci.2012.06.012_b0030) 2007; 23 Beadling (10.1016/j.transci.2012.06.012_b0035) 2007 Moran (10.1016/j.transci.2012.06.012_b0070) 2008; 343 Hennig (10.1016/j.transci.2012.06.012_b0060) 2004; 72 Miyoshi (10.1016/j.transci.2012.06.012_b0080) 2005; 79 Neil (10.1016/j.transci.2012.06.012_b0120) 2005; 105 Kinet (10.1016/j.transci.2012.06.012_b0105) 2007; 15 Calhoun (10.1016/j.transci.2012.06.012_b0040) 2010 Kulkarni (10.1016/j.transci.2012.06.012_b0135) 2009; 114 Lachgar (10.1016/j.transci.2012.06.012_b0130) 1998; 52 Tarhini (10.1016/j.transci.2012.06.012_b0025) 2009; 41 Yamaoka (10.1016/j.transci.2012.06.012_b0065) 2008; 14 Ayatollahi (10.1016/j.transci.2012.06.012_b0020) 2008; 24 Keramati (10.1016/j.transci.2012.06.012_b0015) 2010; 51 Nakao (10.1016/j.transci.2012.06.012_b0050) 2011; 102 Sadeghian (10.1016/j.transci.2012.06.012_b0090) 2009; 3 Winkler (10.1016/j.transci.2012.06.012_b0125) 2009; 5 Takenouchi (10.1016/j.transci.2012.06.012_b0115) 2007; 81 González-Ordóñez (10.1016/j.transci.2012.06.012_b0075) 2005; 125 He (10.1016/j.transci.2012.06.012_b0085) 2008; 4 Anstee (10.1016/j.transci.2012.06.012_b0045) 2010; 115 Matsuoka (10.1016/j.transci.2012.06.012_b0100) 2005; 26 |
References_xml | – volume: 23 start-page: 365 year: 2007 Mar end-page: 371 ident: b0030 article-title: Clinical manifestations associated with HTLV type I infection: a cross-sectional study publication-title: AIDS Res Hum Retroviruses – volume: 26 start-page: 27 year: 2005 ident: b0100 article-title: Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) publication-title: Retrovirology – volume: 51 start-page: 727 year: 2010 Apr end-page: 729 ident: b0015 article-title: Clinical and laboratory features in adult T-cell leukemia/lymphoma in Khorasan, Iran publication-title: Leuk Lymphoma – volume: 3 start-page: 95 year: 2009 end-page: 98 ident: b0090 article-title: Alloimmunization among transfusion-dependent thalassemia patients publication-title: Asian J Transfus Sci – volume: 343 start-page: 1952 year: 2008 end-page: 1965 ident: b0070 article-title: Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen publication-title: Carbohydr Res – volume: 125 start-page: 382 year: 2005 end-page: 388 ident: b0075 article-title: Blood groups and disease publication-title: Med Clin (Barc) – volume: 15 start-page: 31 year: 2007 ident: b0105 article-title: Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells publication-title: Retrovirology – volume: 138 start-page: 1096 year: 2010 end-page: 1099 ident: b0055 article-title: Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection publication-title: Epidemiol Infect – volume: 79 start-page: 664 year: 2005 end-page: 671 ident: b0080 article-title: Relationship between ABO histo-blood group type and an outbreak of norovirus gastroenteritis among primary and junior high school students: results of questionnaire-based study publication-title: Kansenshogaku Zasshi – volume: 81 start-page: 1506 year: 2007 end-page: 1510 ident: b0115 article-title: GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1 publication-title: J Virol – start-page: 621 year: 2007 end-page: 638 ident: b0035 article-title: Immunohematology publication-title: Henry’s clinical diagnosis and management by laboratory methods – volume: 24 start-page: 6058 year: 2005 end-page: 6068 ident: b0010 article-title: Global epidemiology of HTLV-I infection and associated diseases publication-title: Oncogene – volume: 41 start-page: 498 year: 2009 end-page: 499 ident: b0025 article-title: Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran publication-title: Pathology – volume: 5 start-page: 411 year: 2009 end-page: 413 ident: b0125 article-title: Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans publication-title: Cell Host Microbe – volume: 114 start-page: 2783 year: 2009 end-page: 2792 ident: b0135 article-title: The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry publication-title: Blood – volume: 14 start-page: 4265 year: 2008 end-page: 4272 ident: b0065 article-title: Roles of publication-title: World J Gastroenterol – volume: 72 start-page: 3429 year: 2004 end-page: 3435 ident: b0060 article-title: Heterogeneity among publication-title: Infect Immun – volume: 115 start-page: 4635 year: 2010 end-page: 4643 ident: b0045 article-title: The relationship between blood groups and disease publication-title: Blood – volume: 52 start-page: 436 year: 1998 end-page: 439 ident: b0130 article-title: Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC) publication-title: Biomed Pharmacother – volume: 17 start-page: 558 year: 2010 end-page: 564 ident: b0095 article-title: Blood groups and susceptibility to virus infection: new developments publication-title: Curr Opin Hematol – volume: 25 start-page: 61 year: 2006 end-page: 64 ident: b0140 article-title: Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIV/AIDS-TB co-infected patients in Enugu Urban, Nigeria publication-title: West Afr J Med – volume: 2 start-page: 257 year: 2007 end-page: 264 ident: b0005 article-title: Adult T-cell leukemia/lymphoma and HTLV-I publication-title: Curr Hematol Malig Rep – start-page: 1843 year: 2010 end-page: 1859 ident: b0040 article-title: Erythrocyte antigens and antibodies publication-title: Williams hematology – volume: 105 start-page: 4693 year: 2005 end-page: 4699 ident: b0120 article-title: HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation publication-title: Blood – volume: 102 start-page: 1076 year: 2011 end-page: 1080 ident: b0050 article-title: ABO blood group alleles and the risk of pancreatic cancer in Japanese population publication-title: Cancer Sci – volume: 24 start-page: 1155 year: 2008 end-page: 1158 ident: b0020 article-title: Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in Northeast Iran publication-title: AIDS Res Hum Retroviruses – volume: 4 start-page: 52 year: 2008 end-page: 62 ident: b0085 article-title: Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility publication-title: Cell Host Microbe – volume: 80 start-page: 8291 year: 2006 end-page: 8302 ident: b0110 article-title: Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells publication-title: J Virol – volume: 81 start-page: 1506 year: 2007 ident: 10.1016/j.transci.2012.06.012_b0115 article-title: GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1 publication-title: J Virol doi: 10.1128/JVI.01522-06 – volume: 125 start-page: 382 issue: 10 year: 2005 ident: 10.1016/j.transci.2012.06.012_b0075 article-title: Blood groups and disease publication-title: Med Clin (Barc) doi: 10.1157/13079179 – volume: 25 start-page: 61 issue: 1 year: 2006 ident: 10.1016/j.transci.2012.06.012_b0140 article-title: Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIV/AIDS-TB co-infected patients in Enugu Urban, Nigeria publication-title: West Afr J Med – volume: 4 start-page: 52 issue: 1 year: 2008 ident: 10.1016/j.transci.2012.06.012_b0085 article-title: Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility publication-title: Cell Host Microbe doi: 10.1016/j.chom.2008.06.002 – volume: 51 start-page: 727 issue: 4 year: 2010 ident: 10.1016/j.transci.2012.06.012_b0015 article-title: Clinical and laboratory features in adult T-cell leukemia/lymphoma in Khorasan, Iran publication-title: Leuk Lymphoma doi: 10.3109/10428191003611436 – volume: 5 start-page: 411 issue: 5 year: 2009 ident: 10.1016/j.transci.2012.06.012_b0125 article-title: Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans publication-title: Cell Host Microbe doi: 10.1016/j.chom.2009.04.010 – volume: 2 start-page: 257 year: 2007 ident: 10.1016/j.transci.2012.06.012_b0005 article-title: Adult T-cell leukemia/lymphoma and HTLV-I publication-title: Curr Hematol Malig Rep doi: 10.1007/s11899-007-0035-x – volume: 105 start-page: 4693 issue: 12 year: 2005 ident: 10.1016/j.transci.2012.06.012_b0120 article-title: HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation publication-title: Blood doi: 10.1182/blood-2004-11-4267 – volume: 114 start-page: 2783 issue: 13 year: 2009 ident: 10.1016/j.transci.2012.06.012_b0135 article-title: The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry publication-title: Blood doi: 10.1182/blood-2009-04-215186 – start-page: 621 year: 2007 ident: 10.1016/j.transci.2012.06.012_b0035 article-title: Immunohematology – start-page: 1843 year: 2010 ident: 10.1016/j.transci.2012.06.012_b0040 article-title: Erythrocyte antigens and antibodies – volume: 102 start-page: 1076 issue: 5 year: 2011 ident: 10.1016/j.transci.2012.06.012_b0050 article-title: ABO blood group alleles and the risk of pancreatic cancer in Japanese population publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2011.01907.x – volume: 23 start-page: 365 issue: 3 year: 2007 ident: 10.1016/j.transci.2012.06.012_b0030 article-title: Clinical manifestations associated with HTLV type I infection: a cross-sectional study publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2006.0140 – volume: 3 start-page: 95 year: 2009 ident: 10.1016/j.transci.2012.06.012_b0090 article-title: Alloimmunization among transfusion-dependent thalassemia patients publication-title: Asian J Transfus Sci doi: 10.4103/0973-6247.53884 – volume: 72 start-page: 3429 issue: 6 year: 2004 ident: 10.1016/j.transci.2012.06.012_b0060 article-title: Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA publication-title: Infect Immun doi: 10.1128/IAI.72.6.3429-3435.2004 – volume: 24 start-page: 6058 year: 2005 ident: 10.1016/j.transci.2012.06.012_b0010 article-title: Global epidemiology of HTLV-I infection and associated diseases publication-title: Oncogene doi: 10.1038/sj.onc.1208968 – volume: 26 start-page: 27 issue: 2 year: 2005 ident: 10.1016/j.transci.2012.06.012_b0100 article-title: Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) publication-title: Retrovirology doi: 10.1186/1742-4690-2-27 – volume: 80 start-page: 8291 issue: 17 year: 2006 ident: 10.1016/j.transci.2012.06.012_b0110 article-title: Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells publication-title: J Virol doi: 10.1128/JVI.00389-06 – volume: 343 start-page: 1952 issue: 12 year: 2008 ident: 10.1016/j.transci.2012.06.012_b0070 article-title: Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori publication-title: Carbohydr Res doi: 10.1016/j.carres.2007.12.012 – volume: 115 start-page: 4635 issue: 23 year: 2010 ident: 10.1016/j.transci.2012.06.012_b0045 article-title: The relationship between blood groups and disease publication-title: Blood doi: 10.1182/blood-2010-01-261859 – volume: 14 start-page: 4265 issue: 27 year: 2008 ident: 10.1016/j.transci.2012.06.012_b0065 article-title: Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis publication-title: World J Gastroenterol doi: 10.3748/wjg.14.4265 – volume: 41 start-page: 498 issue: 5 year: 2009 ident: 10.1016/j.transci.2012.06.012_b0025 article-title: Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran publication-title: Pathology doi: 10.1080/00313020903041010 – volume: 79 start-page: 664 issue: 9 year: 2005 ident: 10.1016/j.transci.2012.06.012_b0080 article-title: Relationship between ABO histo-blood group type and an outbreak of norovirus gastroenteritis among primary and junior high school students: results of questionnaire-based study publication-title: Kansenshogaku Zasshi doi: 10.11150/kansenshogakuzasshi1970.79.664 – volume: 138 start-page: 1096 issue: 8 year: 2010 ident: 10.1016/j.transci.2012.06.012_b0055 article-title: Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection publication-title: Epidemiol Infect doi: 10.1017/S0950268809991117 – volume: 15 start-page: 31 issue: 4 year: 2007 ident: 10.1016/j.transci.2012.06.012_b0105 article-title: Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells publication-title: Retrovirology doi: 10.1186/1742-4690-4-31 – volume: 24 start-page: 1155 year: 2008 ident: 10.1016/j.transci.2012.06.012_b0020 article-title: Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in Northeast Iran publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2008.0002 – volume: 17 start-page: 558 issue: 6 year: 2010 ident: 10.1016/j.transci.2012.06.012_b0095 article-title: Blood groups and susceptibility to virus infection: new developments publication-title: Curr Opin Hematol doi: 10.1097/MOH.0b013e32833ece31 – volume: 52 start-page: 436 issue: 10 year: 1998 ident: 10.1016/j.transci.2012.06.012_b0130 article-title: Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC) publication-title: Biomed Pharmacother doi: 10.1016/S0753-3322(99)80021-3 |
SSID | ssj0017196 |
Score | 1.9791765 |
Snippet | The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that... AbstractBackgroundThe frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2–3% in the general population and 0.7% in blood donors in northeast Iran. It is... The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that... Background: The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 151 |
SubjectTerms | Adolescent Adult Antibodies Blood donors Blood group Blood Group Antigens - biosynthesis Blood Group Antigens - immunology Blood groups Case-Control Studies Computer programs Hematology, Oncology, and Palliative Medicine HTLV-I HTLV-I Infections - blood HTLV-I Infections - immunology Human T-lymphotropic virus 1 Humans Infection Middle Aged Prospective Studies software Virus Young Adult |
Title | Is there any relationship between expressions of minor blood group antigens with HTLV-I infection? |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1473050212001565 https://www.clinicalkey.es/playcontent/1-s2.0-S1473050212001565 https://dx.doi.org/10.1016/j.transci.2012.06.012 https://www.ncbi.nlm.nih.gov/pubmed/22858444 https://www.proquest.com/docview/1037244248 https://www.proquest.com/docview/1093474916 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1878-1683 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017196 issn: 1473-0502 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1878-1683 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017196 issn: 1473-0502 databaseCode: .~1 dateStart: 20010201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1878-1683 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017196 issn: 1473-0502 databaseCode: ACRLP dateStart: 20010201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1878-1683 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017196 issn: 1473-0502 databaseCode: AIKHN dateStart: 20010201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1878-1683 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017196 issn: 1473-0502 databaseCode: AKRWK dateStart: 20010201 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KC-KLWD9P27KCr-llN5Pby5OUo-VO2yLaSt-WZLNLI5o7Lin45N_uTLI5Ea0Vn_LBDrtMZmZ_m_3NLMDrMtWYp9ZFk0wmEbrEk0tZGZWFllz7JNGO853PzifzS3x7lV5twWzIhWFaZYj9fUzvonV4Mw7aHK-qavxRIllnyiXKu3xgTjTn6l9k04ffNzQPqWXWZxhp5qkxm2f_J8er5fnAVszwUl0ZT6lum59uw5_dPHTyEB4EACmO-jHuwparH8G9s7BF_hiKRSMY1DlBbi7WA9ftulqJwMkS7ltgv9aNWHrxtaqXa9Ex2EWX5EGSLRfpbAT_pRXzi9NP0UIMtK36zRO4PDm-mM2jcJBCZAnutZGyhBpcUuSYU2jLvIxzjG2MfpppgnSOQpx3bmJJK5YWVM6mFHqcjUtXxEjwO3kK2_Wyds9BaO9jT2tOLJVHi6qIfZHSbVomkhY3OAIc1GdsqDLOh118MQOd7LMJWjesdcO0OqlGcLgRW_VlNu4SmAzfxgw5pBT1DE0EdwnqPwm6JvhuY6RpqLH5zb5GMN1I_mKi_9Lpq8F8DLkv78nktVveUGdxoglhKZz-rU2WoEYC8iN41tveRklKTQlCIr74_8G9hPv81DMU92C7Xd-4fUJabXHQudIB7BzNPpy-5-vi3fz8BwHUKTA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTgJeEN8UGBiJ19DYOdfNE5omppS1faFDe7MSx9aCIK2aTOLP55w4RQjGEG9R4pOjy338HP_uDPC2lApzaWw0TXkSoU0cuZThUVko7nufJMr6euflapqd48cLeXEAJ0MtjKdVhtjfx_QuWoc7k6DNybaqJp84knVK36K8qweWt-AQJcXkERwez8-y1X4zQfG0LzJSnqrmCT1HP2lerU8JpvIkL9F18uTiuhR1HQTtUtHpfbgXMCQ77l_zARzY-iHcXoZd8kdQzBvmcZ1l5OlsN9DdLqstC7QsZr8HAmzdsI1j36p6s2MdiZ11dR4k2fo-nQ3zP2pZtl58juZsYG7V7x_D-emH9UkWhbMUIkOIr42EIeBgkyLHnKJb6nicY2xidLNUEaqzFOWctVNDWjG0prJGUvSxJi5tESMh8OQJjOpNbZ8BU87FjpadWAqHBkURu0LSpSwTTusbHAMO6tMmNBr351181QOj7IsOWtde69oz67gYw7u92LbvtHGTwHT4NnooI6XApykX3CSo_iRom-C-jea6ocH6NxMbw2wv-YuV_sukbwbz0eTBflsmr-3miiaLE0UgS-Dsb2PSBBUSlh_D09729koSYkYoEvH5_7_ca7iTrZcLvZivzl7AXf-kJyy-hFG7u7JHBLza4lVwrB-1aCpG |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+there+any+relationship+between+expressions+of+minor+blood+group+antigens+with+HTLV-I+infection%3F&rft.jtitle=Transfusion+and+apheresis+science&rft.au=Sadeghian%2C+Mohammad+Hadi&rft.au=Keramati%2C+Mohammad+Reza&rft.au=Ayatollahi%2C+Hossein&rft.au=Feizabadi%2C+Atefeh+Shirinzadeh&rft.date=2012-10-01&rft.issn=1473-0502&rft.volume=47&rft.issue=2&rft.spage=151&rft.epage=154&rft_id=info:doi/10.1016%2Fj.transci.2012.06.012&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_transci_2012_06_012 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F14730502%2FS1473050212X00065%2Fcov150h.gif |